Here’s Why ASP Isotopes (ASPI) Shares Re-rated Positively in Q1

Soumya Eswaran

Mon, Jul 7, 2025, 7:46 AM 4 min read

Rogue Funds, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund depreciated 12.4% net of fees in the quarter. The firm anticipates significant volatility in the near future. Because of the Fund's concentration, significant declines as well as significant rises in the total returns throughout the course of the year are not unusual. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025.

In its first quarter 2025 investor letter, Rogue Funds highlighted stocks such as ASP Isotopes Inc. (NASDAQ:ASPI). ASP Isotopes Inc. (NASDAQ:ASPI) is a development-stage advanced materials company specializing in the production, distribution, marketing, and sale of isotopes. The one-month return of ASP Isotopes Inc. (NASDAQ:ASPI) was -25.43%, and its shares gained 125.89% of their value over the last 52 weeks. On July 3, 2025, ASP Isotopes Inc. (NASDAQ:ASPI) stock closed at $6.98 per share, with a market capitalization of $585.45 million.

Rogue Funds stated the following regarding ASP Isotopes Inc. (NASDAQ:ASPI) in its first quarter 2025 investor letter:

"ASP Isotopes Inc. (NASDAQ:ASPI) has begun full production for all three of their plants and the stock price has re-rated positively in response. I believe that Silicon-28 will be sold in the coming weeks, and that Ytterbium will be sold at the end of Q2 or beginning of Q3. This will drive real revenue into the company and will also most likely lead to a serious catalyst in the stock price. I expect a TerraPower deal at any moment, and I believe it is highly likely before Q2 ends. The realization of revenue this quarter combined with a TerraPower deal will most likely have extreme upwards pressure on the stock price, which has a short interest of 35%.